Rheumatology.net

Rheumatology Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Xagena Salute

Pain management is a high priority for patients with rheumatoid arthritis. Muscle relaxants include drugs that reduce muscle spasm ( for example benzodiazepines such as Diazepam ( Valium ), Alprazolam ...


Pegloticase ( Krystexxa ) is a potential new treatment option for patients with chronic gout intolerant to other urate-lowering therapies.An analisys has been performed to investigate safety ( adverse ...


Patients suffering from two serious autoimmune disorders which cause muscular inflammation are at increased risk of developing cardiovascular disease, says a group of Montreal researchers. Christian A ...


Rheumatoid arthritis patients who failed to respond to initial treatment with Rituximab ( MabThera, Rituxan ) ( a chimeric monoclonal antibody against the protein CD20 ) can still be successfully re-t ...


To manage the painful and incapacitating symptoms of rheumatoid arthritis ( RA ), a chronic, inflammatory joint disease, the majority of patients rely on disease-modifying antirheumatic drugs ( DMARDs ...


B cells, precursors of autoantibody-secreting cells, have emerged as promising new therapeutic targets in autoimmune diseases, including rheumatoid arthritis. In particular, B cell depletion with the ...


B cells, precursors of autoantibody-secreting cells, have emerged as promising new therapeutic targets in autoimmune diseases, including rheumatoid arthritis. In particular, B cell depletion with the ...


A chronic autoimmune disease, rheumatoid arthritis is characterized by persistent inflammation of the synovial membrane and progressive joint destruction. Beyond loss of mobility, sufferers face a hig ...


The dietary supplements Glucosamine and Chondroitin sulfate, together or alone, appeared to fare no better than placebo in slowing loss of cartilage in osteoarthritis of the knee, researchers from the ...


Healthcare professionals have previously been informed of the risk of hypertension-related adverse events associated with use of Etoricoxib ( Arcoxia ), and of the contraindication for use of Etoricox ...


B cells, precursors of autoantibody-secreting cells, have emerged as promising new therapeutic targets in autoimmune diseases, including rheumatoid arthritis ( RA ). In particular, B cell depletion wi ...


Systemic lupus erythematosus ( SLE ) can affect nearly any part of the body, including the joints, skin, kidneys, heart, nervous system, and brain. Along with joint pain, muscle pain, unexplained feve ...


Patients with active psoriatic arthritis receiving monthly subcutaneous injections of Golimumab ( Simponi ) experienced significant and sustained improvements in the joint and skin manifestations ...


New data suggests that alcohol may protect against rheumatoid arthritis, with three units a week exhibiting protective effects and ten units a week being more protective still. An alcohol consumptio ...


Treatment with Denosumab 60 mg and 180 mg, ( associated with Methotrexate ) reduces the progression of bone erosion. Denosumab is a fully human monoclonal antibody which binds to and inhibits the R ...